Patent details

Basic Information

Publication number:

EP3492100

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP182023408

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES TO OPGL

French Title of Invention:

ANTICORPS POUR OPGL

German Title of Invention:

ANTIKÖRPER GEGEN OPGL

SPC Number:

Dates

Filing date:

25/06/2002

Grant date:

08/12/2021

EP Publication Date:

05/06/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2021

EP B1 Publication Date:

08/12/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/06/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/12/2021

 

 

Name:

Amgen Fremont Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Name:

Amgen Inc.

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:

Boyle, William

Address:

United States (US)

2

Name:

Martin, Francis

Address:

United States (US)

3

Name:

Davis, Geoffrey

Address:

United States (US)

4

Name:

Corvalan, Jose

Address:

United States (US)

Priority

Priority Number:

301172 P

Priority Date:

26/06/2001

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; A61K 39/395; A61P 19/00; A61P 19/08; A61P 19/10; A61P 3/14; A61P 35/04;

Publication

European Patent Bulletin

Issue number:

202149

Publication date:

08/12/2021

Description:

Grant (B1)

Filing date	Document type	Number of pages